Tapewire

Nasdaq · USD

TSHA

Taysha Gene Therapies, Inc.

Export transactions ↓
Tapewire entity
4549
SEC CIK
0001806310
Parsed reports
120

Last 12 months

Inside the activity.

0 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202501
Jan 202607
Feb 202601
Mar 202600
Apr 202601
May 202600
Jun 202600
Jul 202601
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 06, 2023 Filed Mar 9, 2023 00:38 UTC Disposition to issuerEmployee Stock Option (right to buy) · Derivative 199,500 Not disclosed Strike: $1.95 Not disclosed
Disclosure

SEC source: 0001209191-23-017342 · doc4.xml · derivative · entry 4

Session R.A. II · CIK 0001701846 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 199,500 shares

Expires 2032-11-10

F7 · price: This option was canceled by mutual agreement of the Issuer and the Reporting Person. The Reporting Person received the RSU Award in exchange for the cancellation of this option.

F6 · derivative.exercise_date: Prior to the cancellation of this option, 25% of the total number of shares underlying the option were to vest and become exercisable on November 10, 2023 and the remainder were to vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 00:38 UTC OtherCommon Stock 251,296 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017342 · doc4.xml · nonDerivative · entry 1

Session R.A. II · CIK 0001701846 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,420,842

F1 · kind: Represents Reporting Person's annual incentive compensation for 2021 performance awarded in the discretion of the compensation committee of the Issuer's board of directors (the "RSU Award"). The RSU Award replaced a prior stock option award of 199,500 shares of similar value that was canceled effective March 6, 2023.

F2 · shares: Each share is represented by an RSU. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs are fully vested.

F3 · balance_after: In connection with the Reporting Person's separation from the Issuer, the Reporting Person forfeited 21,374 unvested shares pursuant to a restricted stock award.

Read SEC document
February 02, 2023 Filed Feb 7, 2023 02:12 UTC
Alam KamranChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 149,900 $0.00 Strike: $1.18 $0.00
Disclosure

SEC source: 0001209191-23-007396 · doc4.xml · derivative · entry 3

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,900

Underlying: Common Stock · 149,900 shares

Expires 2033-02-02

F4 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on February 2, 2024 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
February 02, 2023 Filed Feb 7, 2023 02:12 UTC
Alam KamranChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 37,384 $0.00 Strike: $1.18 $0.00
Disclosure

SEC source: 0001209191-23-007396 · doc4.xml · derivative · entry 2

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,384

Underlying: Common Stock · 37,384 shares

Expires 2033-02-02

F3 · derivative.exercise_date: 24,923 shares underlying the option shall vest 25% of the total number of shares underlying the option shall vest and become exercisable on February 2, 2024 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter. The remaining shares underlying the option, not subject to time vesting, shall vest upon the achievement of the closing price of the Issuer's common stock on The Nasdaq Stock Market, LLC of at least $4.00 per share on or before December 31, 2023. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
February 02, 2023 Filed Feb 7, 2023 02:12 UTC
Alam KamranChief Financial Officer
GrantCommon Stock 18,691 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-007396 · doc4.xml · nonDerivative · entry 1

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,812

F1 · shares: Represents a restricted stock unit ("RSU") award. 12,461 RSUs shall vest 25% on each of February 2, 2024, February 2, 2025, February 2, 2026 and February 2, 2027. The remaining RSUs, not subject to time vesting, shall vest upon the achievement of the closing price of the Issuer's common stock on The Nasdaq Stock Market, LLC of at least $4.00 per share on or before December 31, 2023. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.

F2 · price: Each RSU represents a contingent right to receive one share the Issuer's common stock.

Read SEC document
December 30, 2022 Filed Jan 4, 2023 21:51 UTC
Nolan Sean P.Director · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 1,106,131 $0.00 Strike: $2.26 $0.00
Disclosure

SEC source: 0001209191-23-001020 · doc4.xml · derivative · entry 1

Nolan Sean P. · CIK 0001569926 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,106,131

Underlying: Common Stock · 1,106,131 shares

Expires 2032-12-30

F1 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on December 16, 2023 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
December 30, 2022 Filed Jan 4, 2023 21:51 UTC
Nagendran SukumarDirector · President and Head of R&D
GrantStock Option (right to buy) · Derivative 790,093 $0.00 Strike: $2.26 $0.00
Disclosure

SEC source: 0001209191-23-001019 · doc4.xml · derivative · entry 1

Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 790,093

Underlying: Common Stock · 790,093 shares

Expires 2032-12-30

F1 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on December 16, 2023 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
November 10, 2022 Filed Dec 23, 2022 21:15 UTC
Session R.A. IIDirector · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 199,500 $0.00 Strike: $1.95 $0.00
Disclosure

SEC source: 0001209191-22-062615 · doc4.xml · derivative · entry 1

Session R.A. II · CIK 0001701846 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,500

Underlying: Common Stock · 199,500 shares

Expires 2032-11-10

F1 · security: Represents Reporting Person's annual incentive compensation for 2021 performance awarded in the discretion of the compensation committee of the Issuer's board of directors on November 10, 2022.

F2 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on November 10, 2023 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
October 31, 2022 Filed Nov 2, 2022 20:09 UTC
Manning Paul BDirector · 10% owner
PurchaseCommon Stock 1,500,000 $2.00 $3,000,000.00
Disclosure

SEC source: 0001209191-22-055263 · doc4.xml · nonDerivative · entry 1

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,642,202

F1 · balance_after: Consists of 1,500,000 shares of common stock held by Mr. Manning and 142,202 shares of common stock held by Mr. Manning jointly with his spouse.

Read SEC document
August 23, 2022 Filed Aug 24, 2022 20:47 UTC
Alam KamranChief Financial Officer
SaleCommon Stock 3,325 $3.47 $11,537.75
Disclosure

SEC source: 0001209191-22-047353 · doc4.xml · nonDerivative · entry 1

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,121

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.40 to $3.58 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).

Read SEC document
August 22, 2022 Filed Aug 23, 2022 00:05 UTC
Alam KamranChief Financial Officer
SaleCommon Stock 9,717 $3.50 $34,009.50
Disclosure

SEC source: 0001209191-22-047097 · doc4.xml · nonDerivative · entry 3

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,446

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.40 to $3.71 inclusive.

Read SEC document
August 19, 2022 Filed Aug 23, 2022 00:05 UTC
Alam KamranChief Financial Officer
SaleCommon Stock 11,482 $3.75 $43,057.50
Disclosure

SEC source: 0001209191-22-047097 · doc4.xml · nonDerivative · entry 2

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 279,163

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.85 inclusive.

Read SEC document
August 18, 2022 Filed Aug 23, 2022 00:05 UTC
Alam KamranChief Financial Officer
SaleCommon Stock 7,476 $3.87 $28,932.12
Disclosure

SEC source: 0001209191-22-047097 · doc4.xml · nonDerivative · entry 1

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,645

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.80 to $3.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).

Read SEC document
July 06, 2022 Filed Jul 7, 2022 20:30 UTC
PRASAD SUYASHCMO and Head of R&D
SaleCommon Stock 8,956 $3.79 $33,943.24
Disclosure

SEC source: 0001209191-22-041455 · doc4.xml · nonDerivative · entry 2

PRASAD SUYASH · CIK 0001679129 · CMO and Head of R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 530,589

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.45 to $4.00, inclusive.

Read SEC document
July 05, 2022 Filed Jul 7, 2022 20:30 UTC
PRASAD SUYASHCMO and Head of R&D
SaleCommon Stock 3,905 $3.51 $13,706.55
Disclosure

SEC source: 0001209191-22-041455 · doc4.xml · nonDerivative · entry 1

PRASAD SUYASH · CIK 0001679129 · CMO and Head of R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 539,545

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.35 to $3.555, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
July 01, 2022 Filed Jul 1, 2022 22:55 UTC
PRASAD SUYASHCMO and Head of R&D
SaleCommon Stock 23,923 $3.53 $84,448.19
Disclosure

SEC source: 0001209191-22-040356 · doc4.xml · nonDerivative · entry 3

PRASAD SUYASH · CIK 0001679129 · CMO and Head of R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 543,450

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.41 to $3.82, inclusive.

Read SEC document
June 30, 2022 Filed Jul 1, 2022 22:55 UTC
PRASAD SUYASHCMO and Head of R&D
SaleCommon Stock 13,892 $3.72 $51,678.24
Disclosure

SEC source: 0001209191-22-040356 · doc4.xml · nonDerivative · entry 2

PRASAD SUYASH · CIK 0001679129 · CMO and Head of R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 567,373

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.65 to $3.81, inclusive.

Read SEC document
June 29, 2022 Filed Jul 1, 2022 22:55 UTC
PRASAD SUYASHCMO and Head of R&D
SaleCommon Stock 12,324 $3.81 $46,954.44
Disclosure

SEC source: 0001209191-22-040356 · doc4.xml · nonDerivative · entry 1

PRASAD SUYASH · CIK 0001679129 · CMO and Head of R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 581,265

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.64 to $3.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).

Read SEC document
June 17, 2022 Filed Jun 22, 2022 20:41 UTC GrantStock Option (right to buy) · Derivative 15,500 $0.00 Strike: $2.81 $0.00
Disclosure

SEC source: 0001209191-22-038692 · doc4.xml · derivative · entry 1

Sepp-Lorenzino Laura · CIK 0001777421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,500

Underlying: Common Stock · 15,500 shares

Expires 2032-06-17

F1 · derivative.exercise_date: The shares vest on the earlier of June 17, 2023 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director though the applicable vesting date.

Read SEC document
June 17, 2022 Filed Jun 22, 2022 20:40 UTC GrantStock Option (right to buy) · Derivative 15,500 $0.00 Strike: $2.81 $0.00
Disclosure

SEC source: 0001209191-22-038691 · doc4.xml · derivative · entry 1

Donenberg Phillip B. · CIK 0001238120 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,500

Underlying: Common Stock · 15,500 shares

Expires 2032-06-17

F1 · derivative.exercise_date: The shares vest on the earlier of June 17, 2023 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director though the applicable vesting date.

Read SEC document
June 17, 2022 Filed Jun 22, 2022 20:39 UTC GrantStock Option (right to buy) · Derivative 15,500 $0.00 Strike: $2.81 $0.00
Disclosure

SEC source: 0001209191-22-038690 · doc4.xml · derivative · entry 1

Nagendran Sukumar · CIK 0001665124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,500

Underlying: Common Stock · 15,500 shares

Expires 2032-06-17

F1 · derivative.exercise_date: The shares vest on the earlier of June 17, 2023 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director though the applicable vesting date.

Read SEC document
June 17, 2022 Filed Jun 22, 2022 20:38 UTC GrantStock Option (right to buy) · Derivative 15,500 $0.00 Strike: $2.81 $0.00
Disclosure

SEC source: 0001209191-22-038689 · doc4.xml · derivative · entry 1

Nolan Sean P. · CIK 0001569926 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,500

Underlying: Common Stock · 15,500 shares

Expires 2032-06-17

F1 · derivative.exercise_date: The shares vest on the earlier of June 17, 2023 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director though the applicable vesting date.

Read SEC document
June 17, 2022 Filed Jun 22, 2022 20:37 UTC GrantStock Option (right to buy) · Derivative 15,500 $0.00 Strike: $2.81 $0.00
Disclosure

SEC source: 0001209191-22-038687 · doc4.xml · derivative · entry 1

Reape Kathleen · CIK 0001832203 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,500

Underlying: Common Stock · 15,500 shares

Expires 2032-06-17

F1 · derivative.exercise_date: The shares vest on the earlier of June 17, 2023 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director though the applicable vesting date.

Read SEC document
June 17, 2022 Filed Jun 22, 2022 20:36 UTC
Manning Paul BDirector · 10% owner
GrantStock Option (right to buy) · Derivative 15,500 $0.00 Strike: $2.81 $0.00
Disclosure

SEC source: 0001209191-22-038685 · doc4.xml · derivative · entry 1

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,500

Underlying: Common Stock · 15,500 shares

Expires 2032-06-17

F1 · derivative.exercise_date: The shares vest on the earlier of June 17, 2023 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director though the applicable vesting date.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:27 UTC
Alam KamranChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 40,000 $0.00 Strike: $6.52 $0.00
Disclosure

SEC source: 0001209191-22-023863 · doc4.xml · derivative · entry 1

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-04-06

F1 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on April 6, 2023 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:26 UTC
PRASAD SUYASHCMO and Head of R&D
GrantEmployee Stock Option (right to buy) · Derivative 40,325 $0.00 Strike: $6.52 $0.00
Disclosure

SEC source: 0001209191-22-023862 · doc4.xml · derivative · entry 1

PRASAD SUYASH · CIK 0001679129 · CMO and Head of R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,325

Underlying: Common Stock · 40,325 shares

Expires 2032-04-06

F1 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on April 6, 2023 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
February 23, 2022 Filed Feb 25, 2022 21:20 UTC
PRASAD SUYASHCMO and Head of R&D
GrantEmployee Stock Option (right to buy) · Derivative 80,650 $0.00 Strike: $5.96 $0.00
Disclosure

SEC source: 0001209191-22-013163 · doc4.xml · derivative · entry 1

PRASAD SUYASH · CIK 0001679129 · CMO and Head of R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,650

Underlying: Common Stock · 80,650 shares

Expires 2032-02-23

F1 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on February 23, 2023 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
February 23, 2022 Filed Feb 25, 2022 21:17 UTC
Session R.A. IIDirector · President and CEO · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 217,850 $0.00 Strike: $5.96 $0.00
Disclosure

SEC source: 0001209191-22-013156 · doc4.xml · derivative · entry 1

Session R.A. II · CIK 0001701846 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,850

Underlying: Common Stock · 217,850 shares

Expires 2032-02-23

F1 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on February 23, 2023 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
February 23, 2022 Filed Feb 25, 2022 21:18 UTC
Alam KamranChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 80,000 $0.00 Strike: $5.96 $0.00
Disclosure

SEC source: 0001209191-22-013160 · doc4.xml · derivative · entry 1

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2032-02-23

F1 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on February 23, 2023 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
February 03, 2022 Filed Feb 4, 2022 13:28 UTC
Manning Paul BDirector · 10% owner
PurchaseCommon Stock 26,602 $7.84 $208,559.68
Disclosure

SEC source: 0001209191-22-007126 · doc4.xml · nonDerivative · entry 5

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,091,704

F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.725 to $8.00 inclusive.

F3 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB.

Read SEC document
February 03, 2022 Filed Feb 4, 2022 13:28 UTC
Manning Paul BDirector · 10% owner
PurchaseCommon Stock 50,000 $7.84 $392,000.00
Disclosure

SEC source: 0001209191-22-007126 · doc4.xml · nonDerivative · entry 4

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,202

F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.725 to $8.00 inclusive.

F2 · ownership.direct: Shares held by Mr. Manning jointly with his spouse.

Read SEC document
February 02, 2022 Filed Feb 3, 2022 14:21 UTC PurchaseCommon Stock 10,000 $8.01 $80,100.00
Disclosure

SEC source: 0001209191-22-006652 · doc4.xml · nonDerivative · entry 1

Nagendran Sukumar · CIK 0001665124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,226

Read SEC document
February 02, 2022 Filed Feb 3, 2022 12:04 UTC PurchaseCommon Stock 3,000 $7.78 $23,340.00
Disclosure

SEC source: 0001209191-22-006641 · doc4.xml · nonDerivative · entry 1

Donenberg Phillip B. · CIK 0001238120 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Read SEC document
February 02, 2022 Filed Feb 4, 2022 13:28 UTC
Manning Paul BDirector · 10% owner
PurchaseCommon Stock 22,000 $7.77 $170,940.00
Disclosure

SEC source: 0001209191-22-007126 · doc4.xml · nonDerivative · entry 3

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 22,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.63 to $7.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (5).

F4 · ownership.nature: The shares are held directly by BKB G2 Investments LLC ("BKB G2"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB G2, and has shared voting and investment power with respect to the shares held by BKB G2.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 13:28 UTC
Manning Paul BDirector · 10% owner
PurchaseCommon Stock 45,000 $7.77 $349,650.00
Disclosure

SEC source: 0001209191-22-007126 · doc4.xml · nonDerivative · entry 2

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,065,102

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.63 to $7.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (5).

F3 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 13:28 UTC
Manning Paul BDirector · 10% owner
PurchaseCommon Stock 58,000 $7.77 $450,660.00
Disclosure

SEC source: 0001209191-22-007126 · doc4.xml · nonDerivative · entry 1

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,202

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.63 to $7.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (5).

F2 · ownership.direct: Shares held by Mr. Manning jointly with his spouse.

Read SEC document
November 24, 2021 Filed Nov 29, 2021 22:01 UTC
Manning Paul BDirector · 10% owner
PurchaseCommon Stock 2,202 $13.19 $29,044.38
Disclosure

SEC source: 0001209191-21-067005 · doc4.xml · nonDerivative · entry 1

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,202

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.115 to $13.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.direct: Shares held by Mr. Manning jointly with his spouse.

Read SEC document
November 23, 2021 Filed Nov 24, 2021 12:58 UTC
Manning Paul BDirector · 10% owner
PurchaseCommon Stock 20,000 $12.54 $250,800.00
Disclosure

SEC source: 0001209191-21-066702 · doc4.xml · nonDerivative · entry 1

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.10 to $12.96 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.direct: Shares held by Mr. Manning jointly with his spouse.

Read SEC document
November 23, 2021 Filed Dec 8, 2021 21:05 UTC
Session R.A. IIDirector · President and CEO · 10% owner
PurchaseCommon Stock 26,008 $12.65 $329,001.20
Disclosure

SEC source: 0001209191-21-068510 · doc4.xml · nonDerivative · entry 2

Session R.A. II · CIK 0001701846 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,190,920

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.46 to $12.94 inclusive.

Read SEC document
November 23, 2021 Filed Dec 8, 2021 21:05 UTC
Session R.A. IIDirector · President and CEO · 10% owner
PurchaseCommon Stock 16,510 $12.12 $200,101.20
Disclosure

SEC source: 0001209191-21-068510 · doc4.xml · nonDerivative · entry 1

Session R.A. II · CIK 0001701846 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,164,912

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.46 to $12.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2).

Read SEC document
August 20, 2021 Filed Aug 20, 2021 21:52 UTC
Alam KamranChief Financial Officer
SaleCommon Stock 2,094 $17.14 $35,891.16
Disclosure

SEC source: 0001209191-21-052824 · doc4.xml · nonDerivative · entry 5

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,121

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.04 to $17.25 inclusive.

Read SEC document
August 20, 2021 Filed Aug 20, 2021 21:52 UTC
Alam KamranChief Financial Officer
SaleCommon Stock 9,746 $16.70 $162,758.20
Disclosure

SEC source: 0001209191-21-052824 · doc4.xml · nonDerivative · entry 4

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,215

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.03 to $17.02 inclusive.

Read SEC document
August 19, 2021 Filed Aug 20, 2021 21:52 UTC
Alam KamranChief Financial Officer
SaleCommon Stock 613 $17.11 $10,488.43
Disclosure

SEC source: 0001209191-21-052824 · doc4.xml · nonDerivative · entry 3

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,961

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.04 to $17.12 inclusive.

Read SEC document
August 19, 2021 Filed Aug 20, 2021 21:52 UTC
Alam KamranChief Financial Officer
SaleCommon Stock 9,354 $16.43 $153,686.22
Disclosure

SEC source: 0001209191-21-052824 · doc4.xml · nonDerivative · entry 2

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310,574

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.04 to $17.03 inclusive.

Read SEC document
August 18, 2021 Filed Aug 20, 2021 21:52 UTC
Alam KamranChief Financial Officer
SaleCommon Stock 11,193 $17.35 $194,198.55
Disclosure

SEC source: 0001209191-21-052824 · doc4.xml · nonDerivative · entry 1

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 319,928

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.95 to $17.825 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6).

Read SEC document
July 01, 2021 Filed Jul 1, 2021 22:32 UTC
PRASAD SUYASHCMO and Head of R&D
SaleCommon Stock 19,706 $21.12 $416,190.72
Disclosure

SEC source: 0001209191-21-044563 · doc4.xml · nonDerivative · entry 7

PRASAD SUYASH · CIK 0001679129 · CMO and Head of R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 593,589

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.81 to $21.53, inclusive.

Read SEC document
June 30, 2021 Filed Jul 1, 2021 22:32 UTC
PRASAD SUYASHCMO and Head of R&D
SaleCommon Stock 500 $23.70 $11,850.00
Disclosure

SEC source: 0001209191-21-044563 · doc4.xml · nonDerivative · entry 6

PRASAD SUYASH · CIK 0001679129 · CMO and Head of R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 613,295

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.16 to $24.00, inclusive.

Read SEC document
June 30, 2021 Filed Jul 1, 2021 22:32 UTC
PRASAD SUYASHCMO and Head of R&D
SaleCommon Stock 6,202 $22.44 $139,172.88
Disclosure

SEC source: 0001209191-21-044563 · doc4.xml · nonDerivative · entry 5

PRASAD SUYASH · CIK 0001679129 · CMO and Head of R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 613,795

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.15 to $23.11, inclusive.

Read SEC document
June 30, 2021 Filed Jul 1, 2021 22:32 UTC
PRASAD SUYASHCMO and Head of R&D
SaleCommon Stock 13,374 $21.42 $286,471.08
Disclosure

SEC source: 0001209191-21-044563 · doc4.xml · nonDerivative · entry 4

PRASAD SUYASH · CIK 0001679129 · CMO and Head of R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 619,997

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.13 to $22.11, inclusive.

Read SEC document
June 29, 2021 Filed Jul 1, 2021 22:32 UTC
PRASAD SUYASHCMO and Head of R&D
SaleCommon Stock 300 $25.19 $7,557.00
Disclosure

SEC source: 0001209191-21-044563 · doc4.xml · nonDerivative · entry 3

PRASAD SUYASH · CIK 0001679129 · CMO and Head of R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 633,371

F1 · kind: The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.44, inclusive.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.